Pelthos Therapeutics Inc. (PTHS) Misses Q1 EPS by 258c

Pelthos Therapeutics Inc. (NYSE: PTHS) reported Q1 EPS of ($3.09), $2.58 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $10.91 million.

For earnings history and earnings-related data on Pelthos Therapeutics Inc. (PTHS) click here.

You May Also Be Interested In

• Chevron Close To A Deal To Expand Operations In Venezuela - WSJ
• Better's board urges shareholders to reject ex-CEO's control bid
• BTIG on Take-Two Interactive (TTWO) GTA 6 Extended Look: 'Earning a Six Star Wanted Level'